|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 20 F Street NW |
Address2 | Suite 1000 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 45312-12
|
||||||||
|
6. House ID# 342580000
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Christian Shalgian, Director, Division of Advocacy and Health Policy |
Date | 01/20/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
See page three for specific MMM issues.
H.R. 3239 - Safeguarding Access For Every Medicare Patient Act
H.R. 2405/S 1814 - Pandemic All Hazards Preparedness Act
H.R. 3586 - Good Samaritan Health Professionals Act of 2011
H.R. 157 - Health Care Safety Net Enhancement Act of 2011
H.R. 816 - Provider Shield Act of 2011
H.R. 451 - Healthcare Truth and Transparency Act of 2011
H.R. 452 - Medicare Decisions Accountability Act of 2011
H.R. 1256 - Medicare Physician Payment Transparency and Assessment Act of 2011
H.R. 1955 - Children's Access to Reconstructive Evaluation & Surgery (CARES) Act of 2011
H.R. 2055 - Consolidated Appropriations Act, 2012
H.R. 969 - Medical Practice Freedom Act of 2011
H.R. 2205 - Ending Defensive Medicine and Encouraging Innovative Reforms Act of 2011
H.R. 1159To repeal certain provisions of the Patient Protection and Affordable Care Act
S. 1099/H.R. 5 - Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011
S. 756 Medicare Data Access for Transparency and Accountability Act
S. 1173/H.R. 2108 - Ambulatory Surgical Centers Quality and Access Act of 2011
S. 365Budget Control Act of 2011
S. 1627Resident Physician Shortage Reduction Act of 2011
S. 668/H.R. 452Healthcare Bureaucrats Elimination Act
S. 1286Trade Adjustment Assistance Act of 2011
Surgical Workforce Shortage/General Surgery Medicare Bonus
Independent Payment Advisory Board/Health Care Reform
American College of Surgeons National Surgical Quality Improvement Program
Accountable Care Organizations
Graduate Medical Education
AARP Oversight
Electronic Prescribing Issues
Health Insurance Exchanges Created by Patient Protection & Affordable Care Act
Medicare Physician Payment/Sustainable Growth Rate Formula Reform in Debt Ceiling Legislation
Proposed Cuts in Medicare Reimbursement for Imaging Services
Volunteer Liability Protections
Scope of Practice/VA Eye Care
Pediatric Loan Repayment Funding
Medical School Debt
Joint Select Committee on Deficit Reduction
Emergency Care CoordinationField Emergency Medical Services
Health Systems Surge Capacity
ICD-10 Implementation
Patient-Centered Outcomes Research Institute (PCORI)
Super Committee Deficit Reduction
Medicare provider number theft
Prescription Drug User Fee Act (PDUFA)
Medical Device User Fee and Modernization Act (MDUFMA)
Electronic Health Records/Health IT
Medicare EHR Incentive Program
ACO/Shared Savings Program
Pending ASC regulations and legislation
Medicare Physician Fee Schedule Final Rule
Accountable Care Organizations Final Rule
Quality and Value Based Purchasing Provisions of Medicare Physician Fee Schedule Final Rule
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Kristen |
Hedstrom |
|
|
|
John |
Hedstrom |
|
|
|
Matt |
Coffron |
|
|
|
Kristin |
McDonald |
|
|
|
Shawn |
Friesen |
|
|
|
Sara |
Morse |
|
|
|
Bob |
Jasak |
|
|
|
Vinita |
Ollapally |
|
|
|
Sana |
Gokak |
|
|
|
Jill |
Shelly |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
See page six for specific Health Issues.
H.R. 3239 - Safeguarding Access For Every Medicare Patient Act
H.R. 2405/S 1814 - Pandemic All Hazards Preparedness Act
H.R. 3586 - Good Samaritan Health Professionals Act of 2011
H.R. 157 - Health Care Safety Net Enhancement Act of 2011
H.R. 816 - Provider Shield Act of 2011
H.R. 451 - Healthcare Truth and Transparency Act of 2011
H.R. 452 - Medicare Decisions Accountability Act of 2011
H.R. 1256 - Medicare Physician Payment Transparency and Assessment Act of 2011
H.R. 1955 - Children's Access to Reconstructive Evaluation & Surgery (CARES) Act of 2011
H.R. 2055 - Consolidated Appropriations Act, 2012
H.R. 969 - Medical Practice Freedom Act of 2011
H.R. 2205 - Ending Defensive Medicine and Encouraging Innovative Reforms Act of 2011
H.R. 1159To repeal certain provisions of the Patient Protection and Affordable Care Act
S. 1099/H.R. 5 - Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011
S. 756 Medicare Data Access for Transparency and Accountability Act
S. 1173/H.R. 2108 - Ambulatory Surgical Centers Quality and Access Act of 2011
S. 365Budget Control Act of 2011
S. 1627Resident Physician Shortage Reduction Act of 2011
S. 668/H.R. 452Healthcare Bureaucrats Elimination Act
S. 1286Trade Adjustment Assistance Act of 2011
Surgical Workforce Shortage/General Surgery Medicare Bonus
Independent Payment Advisory Board/Health Care Reform
American College of Surgeons National Surgical Quality Improvement Program
Accountable Care Organizations
Graduate Medical Education
AARP Oversight
Electronic Prescribing Issues
Health Insurance Exchanges Created by Patient Protection & Affordable Care Act
Medicare Physician Payment/Sustainable Growth Rate Formula Reform in Debt Ceiling Legislation
Proposed Cuts in Medicare Reimbursement for Imaging Services
Volunteer Liability Protections
Scope of Practice/VA Eye Care
Pediatric Loan Repayment Funding
Medical School Debt
Joint Select Committee on Deficit Reduction
Emergency Care CoordinationField Emergency Medical Services
Health Systems Surge Capacity
ICD-10 Implementation
Patient-Centered Outcomes Research Institute (PCORI)
Super Committee Deficit Reduction
Medicare provider number theft
Prescription Drug User Fee Act (PDUFA)
Medical Device User Fee and Modernization Act (MDUFMA)
Electronic Health Records/Health IT
Medicare EHR Incentive Program
ACO/Shared Savings Program
Pending ASC regulations and legislation
Medicare Physician Fee Schedule Final Rule
Accountable Care Organizations Final Rule
Quality and Value Based Purchasing Provisions of Medicare Physician Fee Schedule Final Rule
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Kristen |
Hedstrom |
|
|
|
John |
Hedstrom |
|
|
|
Matt |
Coffron |
|
|
|
Kristin |
McDonald |
|
|
|
Shawn |
Friesen |
|
|
|
Sara |
Morse |
|
|
|
Bob |
Jasak |
|
|
|
Vinita |
Ollapally |
|
|
|
Sana |
Gokak |
|
|
|
Jill |
Shelley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 2055 - Consolidated Appropriations Act, 2012
FY 2012 Trauma Funding
FY 2012 Cancer Appropriations
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Kristen |
Hedstrom |
|
|
|
John |
Hedstrom |
|
|
|
Matt |
Coffron |
|
|
|
Shawn |
Friesen |
|
|
|
Kristin |
McDonald |
|
|
|
Sara |
Morse |
|
|
|
Bob |
Jasak |
|
|
|
Vinita |
Ollapally |
|
|
|
Sana |
Gokak |
|
|
|
Jill |
Shelly |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Veterans Ophthalmology/Optometery Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christian |
Shalgian |
|
|
|
Kristen |
Hedstrom |
|
|
|
John |
Hedstrom |
|
|
|
Matt |
Coffron |
|
|
|
Kristin |
McDonald |
|
|
|
Shawn |
Friesen |
|
|
|
Sara |
Morse |
|
|
|
Bob |
Jasak |
|
|
|
Vinita |
Ollapally |
|
|
|
Sana |
Gokak |
|
|
|
Jill |
Shelly |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |